港股异动︱维他奶去年纯利同比上升近19%午后不涨反跌逾5%
格隆汇6月20日丨维他奶国际(0345.HK)午后跌逾5%,现报42.3港元,暂成交1.4亿港元,最新总市值449亿港元。维他奶午间公布截至3月31日止年度业绩指,期内实现收入约75.26亿港元,同比上升16%;纯利为6.96亿港元,同比上升近19%。基本每股盈利65.6港仙,拟派末期息每股38港仙。公告发布后,维他奶不涨反跌。值得一提的是,去年6月15日午间发布年报后,股价亦于午后下跌,当日收跌4.25%,收报23.648港元。而当日年报公布的纯利是5.86亿港元,同比下跌5%,为截至当日逾5年来首次出现负增长。此次纯利虽同比上升,但上周四(13日)盘中高见47.25港元,创历史新高,较去前同期股价已翻近一倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.